Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Asian journal of pharmceutical sciences, 2017-03, Vol.12 (2), p.143-148
2017
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
The effect of cephalexin in influencing the pharmacokinetics of a novel drug – 5′-valyl-cytarabine hydrochloride
Ist Teil von
  • Asian journal of pharmceutical sciences, 2017-03, Vol.12 (2), p.143-148
Ort / Verlag
Netherlands: Elsevier B.V
Erscheinungsjahr
2017
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • The bioavailability of 5′-valyl-cytarabine hydrochloride (OPC) was investigated when OPC was co-administered with cephalexin. The results showed that the bioavailability of OPC could be reduced when co-administered with cephalexin, suggesting that the efficacy of a novel drug might be reduced when it came to combination use of β-lactam antibiotics. [Display omitted] The aim of this study is to investigate the pharmacokinetics of 5′-valyl-cytarabine hydrochloride (OPC) when co-administered with cephalexin, which are both the substrates of PepT1. The drugs were administered orally by gavage. Blood samples were collected from the orbital plexus of the rats after oral administration of drug solutions. A new high-performance liquid chromatographic method was validated and used for determination of the two drugs. Pharmacokinetic parameters were calculated using DAS 2.1.1 software with noncompartmental analysis. After oral administration of OPC and co-administration of OPC and cephalexin, there were significant differences in the main pharmacokinetic parameters. The main pharmacokinetic parameters for the OPC group and the co-administrative group were as follows: AUC0-10 (18,168.7 ± 2561.4) ng⋅h/ml and (13,448.5 ± 2544.73) ng⋅h/ml, AUC0-∞ (18,683.1 ± 3066.5) ng⋅h/ml and (13,721.1 ± 2683.0) ng⋅h/ml, Cmax (6654.8 ± 481.3) ng/ml and (4765.1 ± 928.9) ng/ml, respectively. The results showed that the bioavailability of OPC could be reduced when co-administered with cephalexin, suggesting that the efficacy of a novel drug might be reduced when it came to combination use of β-lactam antibiotics.
Sprache
Englisch
Identifikatoren
ISSN: 1818-0876
eISSN: 2221-285X
DOI: 10.1016/j.ajps.2016.08.003
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_12ff36ea875540a38a5f7dfd4d180a9b

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX